I don't believe the allergy vaccine works — I started the treatment and didn't get better.
The manifestations associated with Allergy vaccine These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "I don't believe the allergy vaccine works — I started treatment and didn't get better."This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Understanding the Evolution of Allergy Tests and the Response to Allergy Vaccines
A frequent question in Allergy and Immunology clinics concerns the interpretation of blood tests after the start of allergen-specific immunotherapy (popularly known as allergy shots). It is common for patients to begin treatment and, after a short period, undergo new IgE tests, being surprised by a possible increase in the levels of this antibody and questioning the effectiveness of the treatment. However, understanding the complexity of the immune response is fundamental to correctly evaluating therapeutic success.
The IgE test measures antibodies related to allergic processes and can be evaluated in total or specifically for certain allergens (such as dust mites, dust, mold, or pollen). After starting immunotherapy, it is perfectly normal for there to be a temporary increase in IgE levels—both total and specific—because the body comes into regular contact with the allergenic extracts of the vaccine. This initial laboratory behavior does not mean that the treatment has failed.
How Immunotherapy Works in the Body
The true mechanism by which vaccines control the allergic process is not based on the immediate reduction of IgE, but rather on the remodeling of the immune response. This process involves fundamental steps:
- Activation of Regulatory T Lymphocytes: Immunotherapy stimulates cells known as regulatory T lymphocytes, which play the role of modulating and calming the exaggerated response of the immune system to allergens.
- Production of Blocking Antibodies: Simultaneously, stimulation occurs for the production of IgG4 class antibodies (blocking antibodies). These compete with IgE, preventing it from binding to mast cells and triggering allergic symptoms.
Therefore, a significant drop in IgE levels usually takes a prolonged period, often requiring one to two years of continuous treatment, or it may not even occur sharply, which does not prevent the patient from achieving clinical control and improvement of symptoms.
The Importance of Information and Dialogue with the Expert
The clinical improvement observed by the patient—with the reduction or disappearance of seizures—results from effective immune regulation and the action of blocking antibodies generated by the vaccine. Hasty decisions or premature interruption of treatment based on isolated interpretations of laboratory tests may compromise the long-term benefits of immunotherapy.
If you have any doubts about the progress of your treatment, it is highly recommended that you seek detailed clarification from an allergist and immunologist, as well as consult reliable sources based on scientific evidence. This content is for educational and informational purposes only and does not, under any circumstances, replace consultation, diagnosis, and individualized guidance from a specialist physician.
Developments in Evidence-Based Medicine: The Unified Airway Concept (ARIA/EPOS)
The international ARIA consensuses (Allergic Rhinitis and its Impact on Asthma) and EPOS (European Position Paper on Rhinosinusitis and Nasal Polyps) consolidate the pathophysiological concept of single (unified) air routeThe nasal mucosa, paranasal sinuses, and tracheobronchial tree share the same ciliated pseudostratified respiratory epithelium and the same immunological mechanisms mediated by IgE, mast cells, and eosinophils. Persistent edema of the sinus drainage ostia in uncontrolled allergic rhinitis predisposes to mucociliary stasis, post-nasal drip, recurrent rhinosinusitis, and bronchial hyperreactivity. Evidence-based management integrates nasal hygiene with isotonic/hypertonic saline solution, topical intranasal corticosteroids, environmental control, and... allergen-specific immunotherapy to induce lasting immune tolerance.
💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management
IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances
The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Label Reading, Desensitization, and Food Safety
Avoiding restrictive, empirically based diets without diagnostic confirmation prevents significant nutritional deficiencies, especially in growing children. Proper investigation includes... allergy test specific for protein fractions and protocols of vaccine for milk allergy conducted by specialists. In selected and rigorously monitored cases, modern resources are used. allergy vaccine They complement the comprehensive care of the atopic patient.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
Under the medical concept of a 'single airway', uncontrolled inflammation of the nasal cavities and paranasal sinuses directly impacts the ears (Eustachian tube dysfunction), eyes (rhinoconjunctivitis), sleep quality, and bronchi. In specific subgroups, such as Aspirin-Exacerbated Respiratory Disease (AERD), recurrent nasal polyposis, asthma, and intolerance to COX-1 inhibitor anti-inflammatory drugs are also present, requiring specialized diagnosis to restore the sense of smell and respiratory patency.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond direct physical manifestations, uncontrolled conditions linked to allergy vaccines profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.
Importance of Differential Diagnosis and Detailed Medical History
In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving allergy vaccines may present with completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of flare-ups, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable guide for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnosis and unnecessary treatments.
Frequently Asked Questions in Clinical Practice
Immunological Reactions to Insect Bites and Prevention of Crises: In allergological practice, distinguishing between local inflammatory edema and a systemic allergic reaction is crucial to protecting the patient's life. In mosquito hypersensitivity, a mixed immune response occurs (immediate mediated by IgE and delayed cellular response by T lymphocytes), causing a single bite to reactivate old lesions throughout the body. In reactions to bees and wasps, symptoms distant from the sting site—such as generalized plaques, hoarseness, bronchospasm, or a drop in blood pressure—characterize anaphylaxis and require immediate intervention.
Immunology of the Digestive Mucosa: Gut-Airway Axis and Differential Diagnosis: The balance between commensal microbiota and the digestive mucosa directly regulates systemic immunological tolerance. Proteins such as gliadin can modulate zonulin release in genetically susceptible individuals (carriers of HLA-DQ2 or HLA-DQ8 alleles in celiac disease), increasing intestinal permeability and perpetuating local and extraintestinal inflammatory cascades. Careful distinction between celiac autoimmunity, IgE-mediated wheat allergy, and FODMAP carbohydrate fermentation avoids inappropriate management.
Skin Barrier Health, Immune Inflammation, and Pruritus Control: The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Immunology of Cutaneous Autoimmune Diseases and Integrated Care: At the interface between Clinical Immunology, Dermatology, and Rheumatology, a systemic patient assessment allows for the early recognition of metabolic and joint comorbidities, as well as any coexisting hypersensitivities. Tests such as the Antinuclear Antibody (ANA) and inflammatory markers act as screening tools that only acquire real diagnostic significance when interpreted in light of a detailed physical examination of the skin, nails, scalp, and joints.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Safe immunization, even for those with a history of allergies.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Allergy vaccine It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




